Metraipolis › archive › dc_a00411fc0b68

A new paradigm for retroperitoneal leiomyosarcoma: integrating transcriptomic subtyping and surgical risk stratification for AI-guided drug repurposing — Europe PMC PMID:41716942

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41716942
DOI
10.3389/or.2026.1744721
License (as archived)
solo-consultazione
Archived
2026-11-06T03:36:15.849Z
SHA-256 of the archived text
eb131bd2517c8897253cd6c1203967738613bfa63fa7926485194941b1065505
Stable URL of this page
https://metraipolis.com/documento/dc_a00411fc0b68

How to cite

A new paradigm for retroperitoneal leiomyosarcoma: integrating transcriptomic subtyping and surgical risk stratification for AI-guided drug repurposing — Europe PMC PMID:41716942 — Europe PMC (en), https://europepmc.org/article/MED/41716942 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a00411fc0b68 (Metraipolis archive dc_a00411fc0b68, sha256 eb131bd2517c8897253cd6c1203967738613bfa63fa7926485194941b1065505)
BibTeX
@misc{dca00411fc0b68,
  title = {A new paradigm for retroperitoneal leiomyosarcoma: integrating transcriptomic subtyping and surgical risk stratification for AI-guided drug repurposing — Europe PMC PMID:41716942},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41716942},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a00411fc0b68; sha256 eb131bd2517c8897253cd6c1203967738613bfa63fa7926485194941b1065505},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41716942. Agents can read the archived copy with the MCP tool read_document.